|
1
|
Jia B, Liu W, Gu J, Wang J, Lv W, Zhang W,
Hao Q, Pang Z, Mu N, Zhang W and Guo Q: MiR-7-5p suppresses
stemness and enhances temozolomide sensitivity of drug-resistant
glioblastoma cells by targeting Yin Yang 1. Exp Cell Res.
375:73–81. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
McLendon R, Friedman AH, Bigner D, Van
Meir EG, Brat DJ, Mastrogianakis G, Olson JJ, Mikkelsen T, Lehman
N, Aldape K, et al: Comprehensive genomic characterization defines
human glioblastoma genes and core pathways. Nature. 455:1061–1068.
2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shi F, Guo H, Zhang R, Liu H, Wu L, Wu Q,
Liu J, Liu T and Zhang Q: The PI3K inhibitor GDC-0941 enhances
radiosensitization and reduces chemoresistance to temozolomide in
GBM cell lines. Neuroscience. 346:298–308. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schreck KC and Grossman SA: Role of
temozolomide in the treatment of cancers involving the central
nervous system. Oncology (Williston Park). 32:555–560, 569.
2018.PubMed/NCBI
|
|
5
|
Stephen ZR, Kievit FM, Veiseh O, Chiarelli
PA, Fang C, Wang K, Hatzinger SJ, Ellenbogen RG, Silber JR and
Zhang M: Redox-responsive magnetic nanoparticle for targeted
convection-enhanced delivery of O6-benzylguanine to brain tumors.
ACS Nano. 8:10383–10395. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Stavrovskaya AA, Shushanov SS and
Rybalkina EY: Problems of glioblastoma multiforme drug resistance.
Biochemistry (Mosc). 81:91–100. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Choi S, Yu Y, Grimmer MR, Wahl M, Chang SM
and Costello JF: Temozolomide-associated hypermutation in gliomas.
Neuro Oncol. 20:1300–1309. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang F, Dai CQ, Zhang LR, Bing C, Qin J
and Liu YF: Downregulation of Lgr6 inhibits proliferation and
invasion and increases apoptosis in human colorectal cancer. Int J
Mol Med. 42:625–632. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang W, Ding S and Zhang H, Li J, Zhan J
and Zhang H: G protein-coupled receptor LGR6 is an independent risk
factor for colon adenocarcinoma. Front Med. 13:482–491.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ke J, Ma P, Chen J, Qin J and Qian H: LGR6
promotes the progression of gastric cancer through PI3K/AKT/mTOR
pathway. Onco Targets Ther. 11:3025–3033. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kazanskaya O, Glinka A, del Barco
Barrantes I, Stannek P, Niehrs C and Wu W: R-Spondin2 is a secreted
activator of Wnt/beta-catenin signaling and is required for xenopus
myogenesis. Dev Cell. 7:525–534. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kim KA, Zhao J, Andarmani S, Kakitani M,
Oshima T, Binnerts ME, Abo A, Tomizuka K and Funk WD: R-Spondin
proteins: A novel link to beta-catenin activation. Cell Cycle.
5:23–26. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nam JS, Turcotte TJ, Smith PF, Choi S and
Yoon JK: Mouse cristin/R-spondin family proteins are novel ligands
for the Frizzled 8 and LRP6 receptors and activate
beta-catenin-dependent gene expression. J Biol Chem.
281:13247–13257. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Raslan AA and Yoon JK: R-spondins:
Multi-mode WNT signaling regulators in adult stem cells. Int J
Biochem Cell Biol. 106:26–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang Y, Guo L, Lu X, Cheng C, Sun S, Li
W, Zhao L, Lai C, Zhang S, Yu C, et al: Characterization of Lgr6+
cells as an enriched population of hair cell progenitors compared
to Lgr5+ cells for hair cell generation in the neonatal mouse
cochlea. Front Mol Neurosci. 11(147)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Szenker-Ravi E, Altunoglu U, Leushacke M,
Bosso-Lefèvre C, Khatoo M, Thi Tran H, Naert T, Noelanders R,
Hajamohideen A, Beneteau C, et al: RSPO2 inhibition of RNF43 and
ZNRF3 governs limb development independently of LGR4/5/6. Nature.
557:564–569. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schindler AJ, Watanabe A and Howell SB:
LGR5 and LGR6 in stem cell biology and ovarian cancer. Oncotarget.
9:1346–1355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bin BH, Bhin J, Takaishi M, Toyoshima KE,
Kawamata S, Ito K, Hara T, Watanabe T, Irié T, Takagishi T, et al:
Requirement of zinc transporter ZIP10 for epidermal development:
Implication of the ZIP10-p63 axis in epithelial homeostasis. Proc
Natl Acad Sci USA. 114:12243–12248. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guinot A, Oeztuerk-Winder F and Ventura
JJ: miR-17-92/p38α dysregulation enhances Wnt signaling and selects
Lgr6+ cancer stem-like cells during lung adenocarcinoma
progression. Cancer Res. 76:4012–4022. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Roos A, Dhruv HD, Peng S, Inge LJ, Tuncali
S, Pineda M, Millard N, Mayo Z, Eschbacher JM, Loftus JC, et al:
EGFRvIII-stat5 signaling enhances glioblastoma cell migration and
survival. Mol Cancer Res. 16:1185–1195. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang W, Ding X, Ye H, Wang J, Shao J and
Huang T: Hypoxia enhances the migration and invasion of human
glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
Neuroreport. 29:1578–1585. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang L, Wang J, Jin T, Zhou Y and Chen Q:
FoxG1 facilitates proliferation and inhibits differentiation by
downregulating FoxO/Smad signaling in glioblastoma. Biochem Biophys
Res Commun. 504:46–53. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vainchenker W, Leroy E, Gilles L, Marty C,
Plo I and Constantinescu SN: JAK inhibitors for the treatment of
myeloproliferative neoplasms and other disorders. F1000Res.
7(82)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Berendsen S, Spliet WGM, Geurts M, Van
Hecke W, Seute T, Snijders TJ, Bours V, Bell EH, Chakravarti A and
Robe PA: Epilepsy associates with decreased HIF-1α/STAT5b signaling
in glioblastoma. Cancers (Basel). 11(41)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shen X, Zhang J, Zhang X, Wang Y, Hu Y and
Guo J: Retinoic acid-induced protein 14 (RAI14) promotes
mTOR-mediated inflammation under inflammatory stress and chemical
hypoxia in a U87 glioblastoma cell line. Cell Mol Neurobiol.
39:241–254. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ke XX, Pang Y, Chen K, Zhang D, Wang F,
Zhu S, Mao J, Hu X, Zhang G and Cui H: Knockdown of arsenic
resistance protein 2 inhibits human glioblastoma cell proliferation
through the MAPK/ERK pathway. Oncol Rep. 40:3313–3322.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cheng P, Ma Y, Gao Z and Duan L: High
mobility group box 1 (HMGB1) predicts invasion and poor prognosis
of glioblastoma multiforme via activating AKT signaling in an
autocrine pathway. Med Sci Monit. 24:8916–8924. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nadkarni A, Shrivastav M, Mladek AC,
Schwingler PM, Grogan PT, Chen J and Sarkaria JN: ATM inhibitor
KU-55933 increases the TMZ responsiveness of only inherently TMZ
sensitive GBM cells. J Neurooncol. 110:349–357. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun Z, Xue H, Wei Y, Wang C, Yu R, Wang C,
Wang S, Xu J, Qian M, Meng Q and Li G: Mucin O-glycosylating enzyme
GALNT2 facilitates the malignant character of glioma by activating
the EGFR/PI3K/Akt/mTOR axis. Clin Sci (Lond). 133:1167–1184.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wen YT, Wu AT, Bamodu OA, Wei L, Lin CM,
Yen Y, Chao TY, Mukhopadhyay D, Hsiao M and Huang HS: A novel
multi-target small molecule, LCC-09, inhibits stemness and
therapy-resistant phenotypes of glioblastoma cells by increasing
miR-34a and deregulating the DRD4/Akt/mTOR signaling axis. Cancers
(Basel). 11(1442)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim EH, Jo Y, Sai S, Park MJ, Kim JY, Kim
JS, Lee YJ, Cho JM, Kwak SY, Baek JH, et al: Tumor-treating fields
induce autophagy by blocking the Akt2/miR29b axis in glioblastoma
cells. Oncogene. 38:6630–6646. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
An JX, Ma MH, Zhang CD, Shao S, Zhou NM
and Dai DQ: miR-1236-3p inhibits invasion and metastasis in gastric
cancer by targeting MTA2. Cancer Cell Int. 18(66)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K
and Chen Z: Effects of miR-1236-3p and miR-370-5p on activation of
p21 in various tumors and its inhibition on the growth of lung
cancer cells. Tumour Biol. 39(1010428317710824)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bian T, Jiang D, Liu J, Yuan X, Feng J, Li
Q, Zhang Q, Li X, Liu Y and Zhang J: miR-1236-3p suppresses the
migration and invasion by targeting KLF8 in lung adenocarcinoma
A549 cells. Biochem Biophys Res Commun. 492:461–467.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Torre LA, Bray FI, Siegel RL, Ferlay J,
Lortettieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Huang PY, Kandyba E, Jabouille A, Sjolund
J, Kumar A, Halliwill K, McCreery M, DelRosario R, Kang HC, Wong
CE, et al: Lgr6 is a stem cell marker in mouse skin squamous cell
carcinoma. Nat Genet. 49:1624–1632. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
de Lau W, Barker N, Low TY, Koo BK, Li VS,
Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M,
et al: Lgr5 homologues associate with Wnt receptors and mediate
R-spondin signalling. Nature. 476:293–297. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Glinka A, Dolde C, Kirsch N, Huang YL,
Kazanskaya O, Ingelfinger D, Boutros M, Cruciat CM and Niehrs C:
LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and
Wnt/PCP signalling. EMBO Rep. 12:1055–1061. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lebensohn AM and Rohatgi R: R-spondins can
potentiate WNT signaling without LGRs. Elife.
7(e33126)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chong ZZ, Li F and Maiese K: Employing new
cellular therapeutic targets for Alzheimer's disease: A change for
the better? Curr Neurovasc Res. 2:55–72. 2005.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hers I, Vincent EE and Tavaré JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527.
2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer Cell. 4:257–262. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Angers S and Moon RT: Proximal events in
Wnt signal transduction. Nat Rev Mol Cell Biol. 10:468–477.
2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY,
Xie SD and Qi ST: Akt and β-catenin contribute to TMZ resistance
and EMT of MGMT negative malignant glioma cell line. J Neurol Sci.
367:101–106. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
An JX, Ma ZS, Ma MH, Shao S, Cao FL and
Dai DQ: MiR-1236-3p serves as a new diagnostic and prognostic
biomarker for gastric cancer. Cancer Biomark. 25:127–132.
2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zhu XP, Wang XL, Ma J, Fang YF, Zhang HJ,
Zhang C and Feng MC: Down-regulation of miR-1236-3p is correlated
with clinical progression and unfavorable prognosis in gastric
cancer. Eur Rev Med Pharmacol Sci. 22:5914–5919. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Li QH, Liu Y, Chen S, Zong ZH, Du YP,
Sheng XJ and Zhao Y: circ-CSPP1 promotes proliferation, invasion
and migration of ovarian cancer cells by acting as a miR-1236-3p
sponge. Biomed Pharmacother. 114(108832)2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang Q, Miao S, Li C, Cui K, Ge Q and
Chen Z: S-phase kinase-associated protein 2 impairs the inhibitory
effects of miR-1236-3p on bladder tumors. Am J Transl Res.
10:731–743. 2018.PubMed/NCBI
|
|
54
|
Wang Z, Liu L, Guo X, Guo C and Wang W:
microRNA-1236-3p regulates DDP resistance in lung cancer cells.
Open Med (Wars). 14:41–51. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Carè A, Felicetti F, Meccia E, Bottero L,
Parenza M, Stoppacciaro A, Peschle C and Colombo MP: HOXB7: A key
factor for tumor-associated angiogenic switch. Cancer Res.
61:6532–6539. 2001.PubMed/NCBI
|
|
56
|
Duan X, Liu D, Wang Y and Chen Z: Circular
RNA hsa_circ_0074362 Promotes Glioma Cell Proliferation, Migration,
and invasion by attenuating the inhibition of miR-1236-3p on HOXB7
expression. DNA Cell Biol. 37:917–924. 2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Monterisi S, Lo Riso P, Russo K, Bertalot
G, Vecchi M, Testa G, Di Fiore PP and Bianchi F: HOXB7
overexpression in lung cancer is a hallmark of acquired stem-like
phenotype. Oncogene. 37:3575–3588. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Gao RT, Zhan LP, Meng C, Zhang N, Chang
SM, Yao R and Li C: Homeobox B7 promotes the osteogenic
differentiation potential of mesenchymal stem cells by activating
RUNX2 and transcript of BSP. Int J Clin Exp Med. 8:10459–10470.
2015.PubMed/NCBI
|
|
59
|
Cortesi E and Ventura JJ: Lgr6: From
stemness to cancer progression. J Lung Health Dis. 3:12–15.
2019.PubMed/NCBI
|
